Creative Medical Technology Holdings, Inc.CELZNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank33
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P33
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -7.20% |
| Q2 2025 | -32.56% |
| Q1 2025 | 57.53% |
| Q4 2024 | -18.90% |
| Q3 2024 | -37.09% |
| Q2 2024 | 118.93% |
| Q1 2024 | 20.89% |
| Q4 2023 | -64.80% |
| Q3 2023 | 220.77% |
| Q2 2023 | -2.99% |
| Q1 2023 | -94.06% |
| Q4 2022 | 2224.51% |
| Q3 2022 | -64.99% |
| Q2 2022 | 6496.95% |
| Q1 2022 | -80.00% |
| Q4 2021 | -15.51% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 2893.65% |
| Q3 2018 | -31.33% |
| Q2 2018 | 31.25% |
| Q1 2018 | -96.34% |
| Q4 2017 | -0.45% |
| Q3 2017 | 248.28% |
| Q2 2017 | -57.90% |
| Q1 2017 | 236.73% |
| Q4 2016 | -60.67% |
| Q3 2016 | 150.58% |
| Q2 2016 | 313.11% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |